| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.048 | 0.7 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.059 | 0.7 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.043 | 0.8 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |